The modest, broad shifts the pattern produces
Compared with sharper interventions like keto, the Mediterranean diet tends to move metabolic markers gently but across many fronts at once. Trials and cohorts typically report modest improvements in blood lipids, small reductions in blood pressure, lower fasting glucose and insulin resistance, and reduced markers of systemic inflammation such as C-reactive protein.
The changes are usually smaller in any single marker than what an aggressive low-carb diet shows, but they are spread across the cardiometabolic profile rather than concentrated in glucose alone.
From marker changes to the PREDIMED outcome
What distinguishes the Mediterranean evidence is that it connects to hard outcomes, not just marker shifts. In PREDIMED, the pattern was associated with roughly a 30 percent relative reduction in major cardiovascular events, a stronger endpoint than the surrogate markers most diet studies report.
A relative reduction in a trial population is not a guaranteed personal result, and benefits depend on adherence over years. This is general educational information, not medical advice; interpret your own before-and-after numbers with a qualified clinician who can see your full risk picture.